PTJ
SNTI icon

Paul Tudor Jones’s Senti Biosciences Holdings SNTI Stock Holding History

Paul Tudor Jones’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,559
Closed -$351K – 2623
2021
Q4 		$351K Hold
3,559
– – 0.01% 1728
2021
Q3 		$354K Sell
3,559
-1,441
-29% -$142K 0.01% 1920
2021
Q2 		$497K Buy
+5,000
New +$499K 0.01% 1156

Other funds holding SNTI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Paul Tudor Jones's SNTI Position: Q1 2022 in Review

Paul Tudor Jones sold out of Senti Biosciences Holdings (SNTI) in Q1 2022, closing a stake of 3,559 shares — an estimated $351K sold.

Paul Tudor Jones first reported a position in SNTI in Q2 2021 and held it in 3 quarters. The position peaked at $497K in Q2 2021. 45 funds tracked by Wall St. Rank hold SNTI as of Q1 2022.

  • Paul Tudor Jones reported no remaining Senti Biosciences Holdings position as of Q1 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 3,559 Senti Biosciences Holdings shares in Q1 2022, an estimated $351K.
  • Paul Tudor Jones first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 3 quarters.
  • Paul Tudor Jones's Senti Biosciences Holdings position peaked at $497K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.